NPI: 1689702870 · WOOSTER, OH 44691 · Geriatric Medicine (Family Medicine) Physician · NPI assigned 03/01/2007
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (OFFICE MANAGER) |
| NPI Enumeration Date | 03/01/2007 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,169 | $28K |
| 2019 | 1,575 | $23K |
| 2020 | 667 | $13K |
| 2021 | 709 | $14K |
| 2022 | 917 | $16K |
| 2023 | 414 | $10K |
| 2024 | 312 | $10K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,956 | 2,314 | $87K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 989 | 738 | $12K |
| 80061 | Lipid panel | 1,255 | 1,170 | $8K |
| 90688 | 212 | 196 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 238 | 192 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 85 | 74 | $949.45 |
| 90756 | 73 | 58 | $797.35 | |
| 0013A | 29 | 27 | $747.52 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 150 | 141 | $703.78 |
| 0134A | 49 | 35 | $453.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 72 | 59 | $402.41 |
| 96127 | 168 | 164 | $401.71 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 174 | 149 | $199.81 |
| G0008 | Administration of influenza virus vaccine | 89 | 78 | $198.44 |
| 99406 | 41 | 40 | $163.24 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 31 | 27 | $96.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 17 | 16 | $44.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 52 | 42 | $43.59 |
| 81003 | 17 | 13 | $14.22 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 66 | 46 | $3.12 |